The 2023 ASAS Core Course in Spondyloarthritis is taking place at the Courtyard by Marriot Hotel in Brussels on Friday and Saturday 10 and 11 March 2023.
Now in its 3rd edition, this will be the first time the ASAS Core Course takes place in person!
The ASAS Core Course features a number of engaging, world re-known international speakers all with a wealth of clinical and research experience. The course consists of short, punchy updates on the latest clinical data and emerging scientific insights. With an interactive format including imaging and treatment Workshops, Hot Topics, Viewpoints and Expert Discussions, the course is sure to cater for every delegate’s educational or clinical update need in Spondyloarthritis.
UEMS has accredited the core course with 7 CME credits.
The registration fee of €595,00 includes:
- 1 overnight stay at the Courtyard by Marriott hotel
- Dinner on Friday evening
- Participation in all scientific sessions
- Programme and congress related documents (certificate of attendance, …)
- Coffee and lunch as indicated in the programme
Testimonials from previous courses
The Core Course will be held at the Courtyard by Marriott, which is conveniently located near Brussels Airport, with a regular shuttle service to the hotel. For those coming by car, the Courtyard by Marriott has a private car park and there is a public car park just next door. If you travel to Brussels by train, you can reach the hotel either by metro or taxi (approx. 20 min).
Meet the faculty
Matthew Brown is a clinician-scientist who trained initially in medicine and rheumatology in Sydney, Australia before completing a Doctorate of Medicine based at University of Oxford, focusing on genetics of ankylosing spondylitis. He was appointed Professor of Musculoskeletal Sciences at University of Oxford in 2004. In 2005 he returned to Australia, firstly to University of Queensland, and since 2016, at Queensland University of Technology, where he was Professor and Director of Genomics. In 2013 he was elected to Fellowship of the Australian Academy of Sciences in recognition for his achievements in genetics research. In 2019 he moved to King’s College London and Guy’s and St Thomas’ Hospitals NHS Trust to direct their NIHR Biomedical Research Centre, and in 2021 moved to the position of Chief Scientific Officer of Genomics England. He continues to work in genetics of human diseases, with a particular focus on common and rare bone and joint diseases, and in cancer genomics and personalized medicine. He continues to practice rheumatology, with a particular focus on spondyloarthritis.
Prof. Francesco Ciccia is a MD and phD, specialized in Internal Medicine and Rheumatology at the University of Palermo. In the last years Prof. Ciccia’s research was mainly focused on studying different aspects of innate and adaptive immune activation in the pathogenesis of many systemic rheumatic diseases. His training took place in the University of Palermo and the King’s College of London. Currently, Prof. Ciccia holds the position of Full Professor of Rheumatology at the University della Campania L. Vanvitelli in Naples, Italy. Currently, his research is focused on the study of the role of different innate immune pathways in modulating the pathogenesis of AS, GCA, RA and pSS.
Dirk Elewaut is a Full Professor of Rheumatology and Immunology and Chair of the Department of Rheumatology and Immunology at Ghent University Hospital, Ghent, Belgium, a European League Against Rheumatism (EULAR) and Federation of Clinical Immunology Societies (FOCIS) centre of excellence. He received his medical degree at Ghent University in 1991 and his PhD in 1997 at the same institution. Following his postdoctoral research at the University of California San Diego and the La Jolla Institute for Allergy and Immunology, CA, USA, he joined the faculty of the Department of Rheumatology at Ghent University Hospital in 2001. He has published more than 250 scientific publications and is heading a team of 20 researchers at the Laboratory of Molecular Immunology and Inflammation within this department. The team joined the VIB Inflammation Research Centre in 2015, where Dirk Elewaut has been appointed as Principal Investigator. His research interests are centered around translational aspects of immune regulation to combat inflammatory arthritis and associated joint damage, with a special focus on the link between gut and joint disease in spondyloarthritis.
James Galloway is a Reader and Deputy Director of the King’s College London Centre for Rheumatic Diseases. He is a co-investigator for the British Society for Rheumatology RA biologics register. He has a research interest in pharmacovigilance of targeted therapies used to treat immune mediated rheumatic diseases.
Prof. Dr. Kay-Geert Hermann is a Professor of radiology specialized in musculoskeletal imaging with a focus on arthritides. His research is dedicated mainly to the axial skeleton but the peripheral joints as well. The majority of his research projects are in the field of spondyloarthritis, where he is also connected with other researchers from Canada, Brazil, UK, Germany, and Israel. He has also a strong track in applying innovative technology within medical education and is leading the team behind the BerlinCaseViewer app. He is an active member of ASAS, ISS, ESSR, DGMSR, and DRG and has won the Conrad Wilhelm Roentgen award in 2011, Felix Wachsmann award in 2014, and DVMB research prize in 2015. In 2019 he was promoted to associate professor.
Deepak Jadon, MBBCh(Hons) MRCP(Rheum) PhD, is a Consultant Rheumatologist, Director of the Rheumatology Research Unit, and lead for psoriatic arthritis (PsA) at Addenbrooke’s Hospital, Cambridge University Hospitals NHSFT since 2016. Dr. Jadon has particular expertise in the investigation and management of psoriatic arthritis (PsA), ankylosing spondylitis (AS), spondyloarthritis (SpA) and rheumatoid arthritis (RA). He is qualified in the use of musculoskeletal ultrasound to improve diagnostic accuracy, assessment of disease activity and to take ultrasound-guided synovial tissue biopsies from joints.
Robert Landewé is a professor of rheumatology at the Academic Medical Center / University of Amsterdam and chair of the department of rheumatology at Zuyderland Medical Center Heerlen, The Netherlands. Professor Landewé is involved in outcome research and epidemiological research in the field of rheumatoid arthritis, spondyloarthritis and other rheumatic & musculoskeletal manifestations. He has extensive experience in the design and analysis of clinical trials with a special interest in medical statistics and has authored or co-authored more than 600 articles (H-factor: 107) and book chapters. Professor Landewé is a previous executive committee member of OMERACT, board member and past-president of the Assessment in Spondyloarthritis International Society (ASAS), previous executive board member of the Dutch Society of Rheumatology, executive board member of the METEOR foundation and Council member and chair of the Quality of Care committee of EULAR.
Victoria Navarro Compán, MD, PhD, MsC is a rheumatologist working at the University Hospital La Paz and IdiPaz in Madrid, Spain since 2015. She s did her training as rheumatologist at the University Hospital Virgen Macarena in Sevilla. She spent two periods in international centres of excellence: the first of 4 months in the Charité-Universitätsmedizin in Berlin and the second of 2 and a half years in the Leiden University Medical Center, where she obtained her doctoral degree. Currently, she combines clinical practice and research at La Paz University Hospital and teaching at the Universidad Rey Juan Carlos in Madrid (Spain). Her main focus is in clinical research in the field of spondyloarthritis. She has participated in and led national and international research projects in the area of spondyloarthritis. She is currently a member the ASAS (Assessment of SpondyloArthritis Society) executive committee, also acting as executive secretary, and of the EULAR quality of care committee. She is associate editor of Seminars in Arthritis and Rheumatism journal.
Denis Poddubnyy is a Professor of rheumatology at the Charité University Hospital, Berlin, Germany. In 2008 he completed his PhD thesis related to cardiovascular pathology in ankylosing spondylitis and in 2013 his lecturer qualification thesis dedicated to the topic of ‘Prediction and prevention of disease progression in early axial spondyloarthritis’. Since 2003 his research activities have focused on early diagnosis, treatment, and outcomes in patients with axial spondyloarthritis. Dr Poddubnyy is a member of the executive committee of the Assessment of SpondyloArthritis International Society (ASAS), member of the steering committee of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and author of a number of publications on the topic of spondyloarthritis in peer-reviewed journals and book chapters.
Fabian Proft is a rheumatologist and senior researcher working at the Charité University Hospital Berlin in Germany. He received his medical degree at Munich University, where he also started his medical training and later on rheumatological specialisation. Since 2016 he has been working in the Department of Professor Denis Poddubnyy at Charité Berlin at a dedicated ASAS centre. His main research topics are axial spondyloarthritis and psoriatic arthritis with a strong focus on randomised controlled trials, digitalisation, outcome measures and imaging. He published numerous research articles, reviews and book chapters focusing on spondyloarthritis. Recently, one of his scientific focuses lies in early detection of spondyloarthritis using patient centred digital applications and the use of artificial intelligence for imaging assessment in patients with suspicion of axial spondyloarthritis. He is an active member of the Assessment of SpondyloArthritis International Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and he is part of the EMEUNET Peer-Mentoring subgroup. Furthermore, he currently is the chair of Young-GRAPPA (2021–2024) and served as one of the Young-ASAS Leaders (2021–2023).
Sofia Ramiro, MD, PhD, is a rheumatologist and a senior researcher at Leiden University Medical Center and Zuyderland Medical Center, the Netherlands. She graduated from Medical School at Nova Medical School, Lisbon, Portugal. She completed a Master’s in Epidemiology at Maastricht University and obtained her PhD on long-term outcomes in ankylosing spondylitis at the University of Amsterdam. She is a clinical epidemiologist focusing on outcomes research. Her main interests are axial spondyloarthritis (axSpA), rheumatoid arthritis (RA), imaging and methodological and analytical aspects. Sofia Ramiro served as a Chair for EMEUNET, the Emerging EULAR Network, and also of Young Assessment of Spondyloarthritis international Society (ASAS). She was a member of the EULAR Scientific Committee for 2016-2020 and is currently a member of the ASAS Executive Committee. Sofia Ramiro has authored more than 200 peer-reviewed manuscripts.
Since 2021, Irene van der Horst-Bruinsma is Full Professor in Rheumatology and Head of the Department of Rheumatology at the Radboud University Medical Center in Nijmegen, The Netherlands. Between 1998-2021 she has been working as a senior staff member at the Rheumatology department of the Amsterdam UMC, location VUmc and is head of the Center of Excellence in Ankylosing Spondylitis. Prof. Irene van der Horst-Bruinsma was member of the Executive Committee of ASAS (Assessment of Spondyloarthritis international society) and is now Advisory Board member of ASAS. She is also member of the EUROSpA steering group, of the IGAS steering committee, the EULAR task Force Gender Equity in Academic Rheumatology (GEAR), Executive Board of the Dutch Society of Gender and Health.
Floris van Gaalen graduated from the Faculty of Medicine of the Vrije Universiteit in Amsterdam in 2000. In June 2005 he obtained his doctorate at the University of Leiden. For his thesis he received the 2004 Young Investigator Award from the European League against Rheumatism (EULAR). He completed his specialist training in internal medicine in 2009 and in rheumatology in 2010. Since January 2011 he has been a medical specialist at the Department of Rheumatology of the LUMC in Leiden, the Netherlands. He is the head of the Department of Rheumatology in the Alrijne hospitals and chairman of the scientific committee of the LUMC Department of Rheumatology, a EULAR Centre of Excellence. In the LUMC, he is the rheumatologist of the Leiden SPondyloArthritis Caught Early (SPACE) clinic. Since 2015 he is the vice-chairman of the Spondyloarthritis workgroup of the Nederlandse Vereniging voor Reumatologie (Dutch Society for Rheumatology). He is a member of the CLASSIC and AXIS steering committees, the Executive Committee, and the current ASAS treasurer.